Overview
What is Maxaid?
Maxaid is a 501(C)(3) non-profit subsidiary of the Max Foundation, headquartered in Seattle, Washington. Their primary mission revolves around delivering crucial medications, technology, and services to patients battling cancer and other life-threatening illnesses, focusing on those often overlooked by other organizations. Maxaid collaborates with leading global healthcare manufacturers under the Max Access Solutions umbrella, facilitating humanitarian access to essential oncology products. Through this program, medications are sourced directly from drug manufacturers and distributed to individual patients via the Max Foundation's extensive network of healthcare providers and treatment centers in low- and middle-income countries. This collaboration enables thousands of patients to access much-needed oncology treatments they would otherwise be unable to obtain.
Official website here: www.maxaid.org
Is Maxaid legitimate?
Maxaid is a legitimate nonprofit organization registered as a 501(c)(3) entity. Maxaid submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.maxaid.org
What is the mission statement of Maxaid?
Maxaid is a non-profit organization under the Max Foundation, dedicated to accelerating health equity by delivering medication, technology, and services to patients facing cancer and other critical illnesses. The primary focus of Maxaid is to execute treatment access solutions for oncology and critical illness products in low and middle-income countries, in alignment with the Max Foundation's mission. Maxaid facilitates collaborations with leading global healthcare manufacturers through the Max Access Solutions program, ensuring thousands of patients in underserved regions gain access to essential oncology products they would not have otherwise had access to. Through the patient-centered treatment access model called Max Access Solutions, medicines are procured from drug manufacturers and distributed to individual patients via the Max Foundation's network of healthcare providers and treatment centers.
Official website here: www.maxaid.org
Who is the CEO of Maxaid?
Patricia Garcia-Gonzalez is the Chief Executive Officer of Maxaid. The CEO's salary of Maxaid is $0 and their total compensation is $317,879.
Official website here: www.maxaid.org
What is the revenue of Maxaid?
Who are the executives of Maxaid and what are their salaries?
- Patricia Garcia-Gonzalez (Chief Executive Officer) [Trustee/Director]
- Patricia M Pearce (Cfo & Vp, Administration)
- Paula Boultbee (Board Chair) [Trustee/Director]
- Tracey Higgins (Board Vice Chair) [Trustee/Director]
- Curt Malloy (Board Treasurer) [Trustee/Director]
- Mika Matsuzaki (Board Secretary) [Trustee/Director]
- Jerald Jerry Radich Md (Board Member) [Trustee/Director]
- Susan Jerian (Board Member) [Trustee/Director]
- Mabel Woloj (Board Member) [Trustee/Director]
Official website here: www.maxaid.org
Where can I find the form 990 for Maxaid?
The Maxaid’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.maxaid.org
Learn more at the official website: www.maxaid.org
Mission Statement of Maxaid
Maxaid, a 501(c)(3) non-profit subsidiary of the Max Foundation, is dedicated to accelerating health equity by delivering medication, technology, and services to patients facing cancer and other critical illnesses. Maxaid focuses on those who are not being helped by others, carrying out treatment access solutions for oncology and other critical illness products in low and middle-income countries.
Maxaid facilitates collaborations with leading global healthcare manufacturers through the Max Foundation's humanitarian access program, Max Access Solutions. These collaborations enable thousands of patients in low- and middle-income countries to access much-needed oncology products, which they would not have been able to obtain otherwise. The procuring and channelling of medicines to individual patients is done through the Max Foundation's network of healthcare providers and treatment centers. This patient-centered treatment access model, known as Max Access Solutions, is a crucial component of Maxaid's mission.
Impact
This information is meant to be a general summary of Maxaid. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Maxaid's impact is significant as it helps to provide much-needed oncology products and other critical illness medications to patients in low- and middle-income countries. Through collaborations with leading global healthcare manufacturers, Maxaid enables thousands of patients to access vital medicines that they would not have been able to obtain otherwise. By channeling medicines to individual patients through the Max Foundation's network of healthcare providers and treatment centers, Maxaid plays a crucial role in accelerating health equity and ensuring that no one is left behind in the fight against cancer and other critical illnesses.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2016
Phone
(425) 778-8660
Principal Officer
Patricia Garcia-Gonzalez
Main Address
1107 NE 45TH 230, SEATTLE, WA, 98105
Website
www.maxaid.org
NTEE Category
Code: G00 - Disease
If you are a representative of Maxaid and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.